Brief: Definium Therapeutics Supports White House Executive Order On Mental Health Innovation, Committed To Developing Psychedelic Treatments For Mental Health
19/04/2026 24:43
April 18 (Reuters) - Definium Therapeutics Inc DFTX.O: DEFINIUM THERAPEUTICS INC - SUPPORTS WHITE HOUSE EXECUTIVE ORDER ON MENTAL HEALTH INNOVATION DEFINIUM THERAPEUTICS INC - COMMITTED TO DEVELOPING PSYCHEDELIC TREATMENTS FOR MENTAL HEALTH DEFINIUM THERAPEUTICS INC- DEVELOPING DT120 ODT FOR GENERALIZED ANXIETY DISORDER, MAJOR DEPRESSIVE DISORDER, AND OTHER SERIOUS BRAIN HEALTH DISORDERS Source text: ID:nBw2zznWha Further company coverage: DFTX.O ((Reuters.Briefs@thomsonreuters.com;))